nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—neck—spinal cancer	0.044	0.0567	CbGeAlD
Nilotinib—EPHB2—brainstem—spinal cancer	0.0421	0.0542	CbGeAlD
Nilotinib—MAPK8—brainstem—spinal cancer	0.0336	0.0433	CbGeAlD
Nilotinib—MAPK14—neck—spinal cancer	0.028	0.036	CbGeAlD
Nilotinib—EPHB3—brainstem—spinal cancer	0.0277	0.0357	CbGeAlD
Nilotinib—CDC42BPB—medulla oblongata—spinal cancer	0.0259	0.0334	CbGeAlD
Nilotinib—MAPK8—medulla oblongata—spinal cancer	0.0235	0.0302	CbGeAlD
Nilotinib—EPHA4—brainstem—spinal cancer	0.0232	0.0299	CbGeAlD
Nilotinib—CDC42BPB—spinal cord—spinal cancer	0.0231	0.0298	CbGeAlD
Nilotinib—MAPK14—brainstem—spinal cancer	0.0214	0.0275	CbGeAlD
Nilotinib—MAPK8—ErbB2/ErbB3 signaling events—NF2—spinal cancer	0.0211	0.0944	CbGpPWpGaD
Nilotinib—MAPK8—spinal cord—spinal cancer	0.0209	0.0269	CbGeAlD
Nilotinib—KIT—neck—spinal cancer	0.0184	0.0237	CbGeAlD
Nilotinib—PDGFRB—neck—spinal cancer	0.0179	0.0231	CbGeAlD
Nilotinib—HCK—medulla oblongata—spinal cancer	0.0178	0.0229	CbGeAlD
Nilotinib—EPHB3—spinal cord—spinal cancer	0.0172	0.0222	CbGeAlD
Nilotinib—CYP2B6—Fatty acids—CYP4F22—spinal cancer	0.0165	0.0737	CbGpPWpGaD
Nilotinib—EPHA4—medulla oblongata—spinal cancer	0.0162	0.0208	CbGeAlD
Nilotinib—HCK—spinal cord—spinal cancer	0.0159	0.0204	CbGeAlD
Nilotinib—MAP2K5—brainstem—spinal cancer	0.0158	0.0204	CbGeAlD
Nilotinib—MAPK8—Regulation of Androgen receptor activity—SMARCE1—spinal cancer	0.0157	0.0703	CbGpPWpGaD
Nilotinib—CA14—medulla oblongata—spinal cancer	0.0145	0.0187	CbGeAlD
Nilotinib—EPHB4—medulla oblongata—spinal cancer	0.0141	0.0182	CbGeAlD
Nilotinib—KIT—brainstem—spinal cancer	0.014	0.0181	CbGeAlD
Nilotinib—CYP2D6—Miscellaneous substrates—CYP4F22—spinal cancer	0.0137	0.0612	CbGpPWpGaD
Nilotinib—TEK—medulla oblongata—spinal cancer	0.0135	0.0174	CbGeAlD
Nilotinib—MAPK14—spinal cord—spinal cancer	0.0133	0.0171	CbGeAlD
Nilotinib—CA4—neck—spinal cancer	0.0131	0.0169	CbGeAlD
Nilotinib—CA14—spinal cord—spinal cancer	0.0129	0.0166	CbGeAlD
Nilotinib—EPHB6—medulla oblongata—spinal cancer	0.0129	0.0166	CbGeAlD
Nilotinib—EPHB4—spinal cord—spinal cancer	0.0126	0.0162	CbGeAlD
Nilotinib—ABL1—brainstem—spinal cancer	0.0122	0.0157	CbGeAlD
Nilotinib—TEK—spinal cord—spinal cancer	0.0121	0.0155	CbGeAlD
Nilotinib—EPHB6—spinal cord—spinal cancer	0.0115	0.0148	CbGeAlD
Nilotinib—CYP2D6—Fatty acids—CYP4F22—spinal cancer	0.0115	0.0512	CbGpPWpGaD
Nilotinib—MAP2K5—medulla oblongata—spinal cancer	0.011	0.0142	CbGeAlD
Nilotinib—PDGFRA—spinal cord—spinal cancer	0.0109	0.0141	CbGeAlD
Nilotinib—CA2—neck—spinal cancer	0.0109	0.014	CbGeAlD
Nilotinib—CSF1R—medulla oblongata—spinal cancer	0.0108	0.0139	CbGeAlD
Nilotinib—CA4—brainstem—spinal cancer	0.01	0.0129	CbGeAlD
Nilotinib—MAP2K5—spinal cord—spinal cancer	0.00985	0.0127	CbGeAlD
Nilotinib—KIT—medulla oblongata—spinal cancer	0.00979	0.0126	CbGeAlD
Nilotinib—CSF1R—spinal cord—spinal cancer	0.00961	0.0124	CbGeAlD
Nilotinib—PDGFRB—medulla oblongata—spinal cancer	0.00956	0.0123	CbGeAlD
Nilotinib—MAPK14—Regulation of Androgen receptor activity—SMARCE1—spinal cancer	0.00895	0.04	CbGpPWpGaD
Nilotinib—KIT—spinal cord—spinal cancer	0.00873	0.0112	CbGeAlD
Nilotinib—PDGFRB—spinal cord—spinal cancer	0.00853	0.011	CbGeAlD
Nilotinib—ABL1—medulla oblongata—spinal cancer	0.00852	0.011	CbGeAlD
Nilotinib—CA2—brainstem—spinal cancer	0.00832	0.0107	CbGeAlD
Nilotinib—CA1—spinal cord—spinal cancer	0.00798	0.0103	CbGeAlD
Nilotinib—ABL1—spinal cord—spinal cancer	0.0076	0.00979	CbGeAlD
Nilotinib—CA4—medulla oblongata—spinal cancer	0.007	0.00902	CbGeAlD
Nilotinib—CA4—spinal cord—spinal cancer	0.00624	0.00804	CbGeAlD
Nilotinib—CA2—medulla oblongata—spinal cancer	0.0058	0.00748	CbGeAlD
Nilotinib—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.00544	0.0243	CbGpPWpGaD
Nilotinib—ABCG2—medulla oblongata—spinal cancer	0.00537	0.00692	CbGeAlD
Nilotinib—CYP2B6—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.00537	0.024	CbGpPWpGaD
Nilotinib—CYP2C8—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.00533	0.0238	CbGpPWpGaD
Nilotinib—CYP2D6—brainstem—spinal cancer	0.00528	0.00681	CbGeAlD
Nilotinib—CA2—spinal cord—spinal cancer	0.00517	0.00667	CbGeAlD
Nilotinib—ABCG2—spinal cord—spinal cancer	0.00479	0.00617	CbGeAlD
Nilotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.00461	0.0206	CbGpPWpGaD
Nilotinib—CYP2C8—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.00455	0.0203	CbGpPWpGaD
Nilotinib—CYP2B6—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.00441	0.0197	CbGpPWpGaD
Nilotinib—CA3—Metabolism—MRI1—spinal cancer	0.00439	0.0196	CbGpPWpGaD
Nilotinib—CYP2C9—Arachidonic acid metabolism—CYP4F22—spinal cancer	0.00434	0.0194	CbGpPWpGaD
Nilotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.00378	0.0169	CbGpPWpGaD
Nilotinib—UGT1A1—Biological oxidations—CYP4F22—spinal cancer	0.00377	0.0168	CbGpPWpGaD
Nilotinib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.00375	0.0168	CbGpPWpGaD
Nilotinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.00374	0.0167	CbGpPWpGaD
Nilotinib—CYP2D6—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.00373	0.0167	CbGpPWpGaD
Nilotinib—UGT1A1—Metapathway biotransformation—CYP4F22—spinal cancer	0.00372	0.0166	CbGpPWpGaD
Nilotinib—CYP2C9—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.0037	0.0165	CbGpPWpGaD
Nilotinib—CA3—Metabolism—CYP4F22—spinal cancer	0.00309	0.0138	CbGpPWpGaD
Nilotinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.00307	0.0137	CbGpPWpGaD
Nilotinib—CYP2C9—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.00304	0.0136	CbGpPWpGaD
Nilotinib—CA14—Metabolism—MRI1—spinal cancer	0.00283	0.0126	CbGpPWpGaD
Nilotinib—CA6—Metabolism—MRI1—spinal cancer	0.00276	0.0123	CbGpPWpGaD
Nilotinib—ABCB1—medulla oblongata—spinal cancer	0.00265	0.00341	CbGeAlD
Nilotinib—CA7—Metabolism—MRI1—spinal cancer	0.00257	0.0115	CbGpPWpGaD
Nilotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4F22—spinal cancer	0.00247	0.011	CbGpPWpGaD
Nilotinib—CYP3A4—Oxidation by Cytochrome P450—CYP4F22—spinal cancer	0.00244	0.0109	CbGpPWpGaD
Nilotinib—CA12—Metabolism—MRI1—spinal cancer	0.00238	0.0106	CbGpPWpGaD
Nilotinib—ABCB1—spinal cord—spinal cancer	0.00236	0.00304	CbGeAlD
Nilotinib—CYP2B6—Biological oxidations—CYP4F22—spinal cancer	0.00234	0.0105	CbGpPWpGaD
Nilotinib—CYP2B6—Metapathway biotransformation—CYP4F22—spinal cancer	0.00231	0.0103	CbGpPWpGaD
Nilotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F22—spinal cancer	0.002	0.00896	CbGpPWpGaD
Nilotinib—CA14—Metabolism—CYP4F22—spinal cancer	0.00199	0.0089	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—CYP4F22—spinal cancer	0.00198	0.00886	CbGpPWpGaD
Nilotinib—CYP2C8—Metapathway biotransformation—CYP4F22—spinal cancer	0.00196	0.00874	CbGpPWpGaD
Nilotinib—CA6—Metabolism—CYP4F22—spinal cancer	0.00194	0.00867	CbGpPWpGaD
Nilotinib—CA4—Metabolism—MRI1—spinal cancer	0.0019	0.00849	CbGpPWpGaD
Nilotinib—CA2—Metabolism—MRI1—spinal cancer	0.00182	0.00814	CbGpPWpGaD
Nilotinib—CA7—Metabolism—CYP4F22—spinal cancer	0.00181	0.0081	CbGpPWpGaD
Nilotinib—CA1—Metabolism—MRI1—spinal cancer	0.00175	0.0078	CbGpPWpGaD
Nilotinib—CA12—Metabolism—CYP4F22—spinal cancer	0.00168	0.0075	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—CYP4F22—spinal cancer	0.00163	0.00728	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—CYP4F22—spinal cancer	0.00161	0.00721	CbGpPWpGaD
Nilotinib—CYP2D6—Metapathway biotransformation—CYP4F22—spinal cancer	0.00161	0.00718	CbGpPWpGaD
Nilotinib—CYP2C9—Metapathway biotransformation—CYP4F22—spinal cancer	0.00159	0.00712	CbGpPWpGaD
Nilotinib—CA9—Metabolism—MRI1—spinal cancer	0.00154	0.00686	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CYP4F22—spinal cancer	0.00134	0.00598	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CYP4F22—spinal cancer	0.00128	0.00574	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CYP4F22—spinal cancer	0.00123	0.0055	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CYP4F22—spinal cancer	0.00108	0.00483	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—CYP4F22—spinal cancer	0.00106	0.00476	CbGpPWpGaD
Nilotinib—CYP3A4—Metapathway biotransformation—CYP4F22—spinal cancer	0.00105	0.00469	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MRI1—spinal cancer	0.000915	0.00409	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MRI1—spinal cancer	0.000776	0.00347	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.000762	0.0034	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP4F22—spinal cancer	0.000644	0.00288	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP4F22—spinal cancer	0.00062	0.00277	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MRI1—spinal cancer	0.000569	0.00254	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP4F22—spinal cancer	0.000547	0.00244	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MRI1—spinal cancer	0.000482	0.00215	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MRI1—spinal cancer	0.00042	0.00187	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP4F22—spinal cancer	0.000401	0.00179	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MRI1—spinal cancer	0.000395	0.00177	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MRI1—spinal cancer	0.000392	0.00175	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP4F22—spinal cancer	0.000339	0.00152	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP4F22—spinal cancer	0.000296	0.00132	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP4F22—spinal cancer	0.000279	0.00124	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP4F22—spinal cancer	0.000276	0.00123	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MRI1—spinal cancer	0.000258	0.00115	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP4F22—spinal cancer	0.000182	0.000814	CbGpPWpGaD
